Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

17.4%

4 terminated/withdrawn out of 23 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 16 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
6(60.0%)
Phase 2
4(40.0%)
10Total
N/A(6)
Phase 2(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (23)

Showing 20 of 23 trials
NCT02740361Not ApplicableCompleted

Online Program to Reduce Depression in MS

Role: collaborator

NCT04301271Phase 2Completed

Simvastatin add-on Treatment to Standard Antidepressant Therapy in Patients With Comorbid Obesity and Major Depression

Role: collaborator

NCT03205306Completed

Myasthenia Gravis and Psyche

Role: collaborator

NCT03884153Not ApplicableUnknown

CASTRO-B - Study on CRP Apheresis in STROke Patients in Berlin

Role: collaborator

NCT03884166Unknown

MUcociliary Clearance IN Stroke

Role: collaborator

NCT03097146Not ApplicableCompleted

Managing Aftercare for Stroke (MAS): MAS-II - A Longitudinal Complex-interventional Study in Post-rehabilitation Stroke Patients

Role: collaborator

NCT01264549Not ApplicableCompleted

Stroke Adverse Outcome is Associated With Nosocomial Infections: PCTus- Guided Antibacterial Therapy in Severe Ischemic Stroke Patients (STRAWINSKI)

Role: collaborator

NCT03979521Completed

Burden of Disease in Myasthenia Gravis

Role: collaborator

NCT02320994Completed

Managing Aftercare for Stroke (MAS): MAS-I - a Cross Sectional Study of Post-rehabilitation Stroke Burden and Patients' Needs

Role: collaborator

NCT01079728Completed

Prediction of Stroke-associated Pneumonia

Role: collaborator

NCT04158661Unknown

Influence of Minimally Invasive Thymectomy on the Subsequent Clinical Course of Myasthenia Gravis

Role: collaborator

NCT02740296Completed

Depression and Immune Function in Multiple Sclerosis (MS)

Role: collaborator

NCT01647880Phase 2Terminated

MOdification of VIsual Outcomes After Optic Neuritis in CIS or MS by Gilenya (MOVING Study)

Role: collaborator

NCT01440062Phase 2Terminated

Efficacy of Vitamin D Supplementation in Multiple Sclerosis (EVIDIMS)

Role: collaborator

NCT02695394Completed

Emotional Processing in Multiple Sclerosis / Clinically Isolated Syndrome: A Neuropsychological fMRI-study

Role: collaborator

NCT01102192Completed

The Role of the Thymus in Myasthenia Gravis

Role: collaborator

NCT03062150Not ApplicableCompleted

Mineralocorticoid Receptor, NMDA Receptor and Cognitive Function in Depression

Role: collaborator

NCT02102594Phase 2Terminated

Therapy of Antibody-mediated Autoimmune Diseases by Bortezomib (TAVAB)

Role: collaborator

NCT01463995Completed

Prognosis in Neurological Intensive Care Unit Patients (proNICU Cohort)

Role: collaborator

NCT02008604Completed

Influence of Stroke on the Composition of Intestinal Microbiota

Role: collaborator